News | Magnetic Resonance Imaging (MRI) | June 15, 2020

Canon Medical Receives FDA Clearance for Compressed SPEEDER Technology for 1.5T MR

New software version for Vantage Orian 1.5T also offers cybersecurity solutions to protect patient data

New software version for Vantage Orian 1.5T also offers cybersecurity solutions to protect patient data

June 15, 2020 — Hospitals and institutions are continually looking for ways to improve diagnostic imaging throughput, especially in today’s environment where disinfection of systems and rooms in between patients is crucial. Now, with the newly FDA-cleared Compressed SPEEDER technology for Canon Medical Systems USA, Inc.’s Vantage Orian 1.5T MR system, clinicians can speed up magnetic resonance imaging (MRI) scan times by reconstructing full resolution images from under-sampled data through iterative reconstruction, improving throughput and allowing for substantial time in between exams to help clean or disinfect the scanner if necessary.

Scan times for MRIs have historically been a challenge. To reduce acquisition times, Compressed SPEEDER, also available on the Vantage Galan 3T MR system, supports image acceleration and can be used to avoid unfolding error artifacts sometimes seen with standard parallel imaging, or can achieve higher resolution in 2-D Fast Spin Echo (FSE) acquisitions. Reduced scan times also enhance patient comfort, which in turn may enable higher quality images by mitigating patient movement caused by patient discomfort during long scans.

Compressed SPEEDER is included in an all-new new version of M-Power software available for the Vantage Orian 1.5T, which also comes standard with Windows 10 and embedded cybersecurity solutions from Canon Medical. Patient data is kept secure with continuous patches and updates from Microsoft, as well as whitelisting functions, which give clinicians access only to applications and processes which have been authorized.

“In MR imaging, shortening scan times is vastly important for both the patient and physician. At Canon Medical, our priority is to support our customers and their patients by providing them with timely advancements that can impact their outcomes and workflow,” said Jonathan Furuyama, managing director, MR Business Unit, Canon Medical Systems USA, Inc. “With the help of Compressed SPEEDER along with Windows 10 on the Vantage Orian 1.5T MR system, healthcare providers can offer a quick, comfortable and safe experience for their patients.”

Foe more information: https://us.medical.canon

Related Content

Image courtesy of GE Healthcare

Feature | Mobile C-Arms | July 08, 2020 | By Melinda Taschetta-Millane
Moblie C-arms have seen several advances over the past de
 Many patients with severe coronavirus disease 2019 (COVID-19) remain unresponsive after surviving critical illness. Investigators led by a team at Massachusetts General Hospital (MGH) now describe a patient with severe COVID-19 who, despite prolonged unresponsiveness and structural brain abnormalities, demonstrated functionally intact brain connections and weeks later he recovered the ability to follow commands

Getty Images

News | Coronavirus (COVID-19) | July 08, 2020
July 8, 2020 — Many patients with severe coronavirus disease 2019 (...
Fujifilm’s Sonosite SII POC ultrasound system helps to keep crowded areas clearer with a small ultrasound footprint.

Fujifilm’s Sonosite SII POC ultrasound system helps to keep crowded areas clearer with a small ultrasound footprint.

Feature | Ultrasound Imaging | July 07, 2020 | By Joan Toth
With the miniaturization of technology, improved ease of use, lower system cost, increased portability and greater ac
A patient implanted with the Axonics System can undergo MRI examinations safely with radio frequency (RF) Transmit Body or Head Coil under the conditions outlined in the Axonics MRI Conditional Guidelines.

A patient implanted with the Axonics System can undergo MRI examinations safely with radio frequency (RF) Transmit Body or Head Coil under the conditions outlined in the Axonics MRI Conditional Guidelines.

News | Magnetic Resonance Imaging (MRI) | July 02, 2020
July 2, 2020 — Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commerci
This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
A 3-D ultrasound system provides an effective, noninvasive way to estimate blood flow that retains its accuracy across different equipment, operators and facilities, according to a study published in the journal Radiology.

Volume flow as a function of color flow gain (at a single testing site). For each row the color flow c-plane and the computed volume flow are shown as a function of color flow gain. The c-plane is shown for four representative gain levels, whereas the computed volume flow is shown for 12–17 steps across the available gain settings. Flow was computed with (solid circles on the graphs) and without (hollow circles on the graphs) partial volume correction. Partial volume correction accounts for pixels that are only partially inside the lumen. Therefore, high gain (ie, blooming) does not result in overestimation of flow. Systems 1 and 2 converge to true flow after the lumen is filled with color pixel. System 3 is nearly constant regarding gain and underestimates the flow by approximately 17%. Shown are mean flow estimated from 20 volumes, and the error bars show standard deviation. Image courtesy of the journal Radiology

News | Ultrasound Imaging | July 01, 2020
July 1, 2020 — A 3-D ultrasound
Researchers reviewed results of prostate biopsies on over 3,400 men who had targets identified on prostate MRI and found that the positive predictive value of the test for prostate cancer was highly variable at different sites
News | Prostate Cancer | July 01, 2020
July 1, 2020 — Prostate MRI is an emerging technology used to identify and guide treatment for...
R2* maps of healthy control participants and participants with Alzheimer disease. R2* maps are windowed between 10 and 50 sec21. Differences in iron concentration in basal ganglia are too small to allow visual separation between patients with Alzheimer disease and control participants, and iron levels strongly depend on anatomic structure and subject age. Image courtesy of Radiological Society of North America

R2* maps of healthy control participants and participants with Alzheimer disease. R2* maps are windowed between 10 and 50 sec21. Differences in iron concentration in basal ganglia are too small to allow visual separation between patients with Alzheimer disease and control participants, and iron levels strongly depend on anatomic structure and subject age. Image courtesy of Radiological Society of North America

News | Magnetic Resonance Imaging (MRI) | July 01, 2020
July 1, 2020 — Researchers using magnetic...